Business Description
Thermo Fisher Scientific Inc
NAICS : 541380
SIC : 3826
ISIN : US8835561023
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.72 | |||||
Debt-to-EBITDA | 3.07 | |||||
Interest Coverage | 5.06 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.88 | |||||
Beneish M-Score | -2.61 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11 | |||||
3-Year EBITDA Growth Rate | 4.1 | |||||
3-Year EPS without NRI Growth Rate | 3.3 | |||||
3-Year FCF Growth Rate | 1.5 | |||||
3-Year Book Growth Rate | 11.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 6.75 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.15 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.66 | |||||
9-Day RSI | 46.69 | |||||
14-Day RSI | 44.58 | |||||
3-1 Month Momentum % | -11.33 | |||||
6-1 Month Momentum % | -5.37 | |||||
12-1 Month Momentum % | 4.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 1.26 | |||||
Cash Ratio | 0.46 | |||||
Days Inventory | 76.36 | |||||
Days Sales Outstanding | 70.16 | |||||
Days Payable | 38.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.3 | |||||
Dividend Payout Ratio | 0.07 | |||||
3-Year Dividend Growth Rate | 16.7 | |||||
Forward Dividend Yield % | 0.3 | |||||
5-Year Yield-on-Cost % | 0.61 | |||||
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | 1.52 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.77 | |||||
Operating Margin % | 17.48 | |||||
Net Margin % | 14.48 | |||||
FCF Margin % | 18.35 | |||||
ROE % | 13.11 | |||||
ROA % | 6.24 | |||||
ROIC % | 8.02 | |||||
3-Year ROIIC % | 0.08 | |||||
ROC (Joel Greenblatt) % | 56.44 | |||||
ROCE % | 9.87 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.03 | |||||
Forward PE Ratio | 22.47 | |||||
PE Ratio without NRI | 24.58 | |||||
Shiller PE Ratio | 40.11 | |||||
Price-to-Owner-Earnings | 28.85 | |||||
PEG Ratio | 1.62 | |||||
PS Ratio | 4.78 | |||||
PB Ratio | 4.11 | |||||
Price-to-Free-Cash-Flow | 26.12 | |||||
Price-to-Operating-Cash-Flow | 22.32 | |||||
EV-to-EBIT | 27.74 | |||||
EV-to-Forward-EBIT | 24.74 | |||||
EV-to-EBITDA | 20.01 | |||||
EV-to-Forward-EBITDA | 20.01 | |||||
EV-to-Revenue | 5.43 | |||||
EV-to-Forward-Revenue | 5.08 | |||||
EV-to-FCF | 29.61 | |||||
Price-to-GF-Value | 0.94 | |||||
Price-to-Projected-FCF | 1.55 | |||||
Price-to-DCF (Earnings Based) | 0.79 | |||||
Price-to-DCF (FCF Based) | 1.1 | |||||
Price-to-Median-PS-Value | 1.04 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.27 | |||||
Earnings Yield (Greenblatt) % | 3.6 | |||||
FCF Yield % | 3.86 | |||||
Forward Rate of Return (Yacktman) % | 13.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:TMO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Thermo Fisher Scientific Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 42,370 | ||
EPS (TTM) ($) | 15.95 | ||
Beta | 0.95 | ||
3-Year Sharpe Ratio | -0.29 | ||
3-Year Sortino Ratio | -0.38 | ||
Volatility % | 19.85 | ||
14-Day RSI | 44.58 | ||
14-Day ATR ($) | 10.564551 | ||
20-Day SMA ($) | 522.3475 | ||
12-1 Month Momentum % | 4.5 | ||
52-Week Range ($) | 493.3 - 627.88 | ||
Shares Outstanding (Mil) | 382.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Thermo Fisher Scientific Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Thermo Fisher Scientific Inc Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Thermo Fisher Scientific Inc Frequently Asked Questions
What is Thermo Fisher Scientific Inc(TMO)'s stock price today?
When is next earnings date of Thermo Fisher Scientific Inc(TMO)?
Does Thermo Fisher Scientific Inc(TMO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |